| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls 1958 Birth Cohort Controls Jones Richard W. 18 McArdle Wendy L. 18 Ring ... Nature 447 (7145), 661-678, 2007 | 9322 | 2007 |
| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378 (6559), 789-792, 1995 | 4897 | 1995 |
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 4711 | 2003 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3958 | 1998 |
| Patterns of somatic mutation in human cancer genomes C Greenman, P Stephens, R Smith, GL Dalgliesh, C Hunter, G Bignell, ... Nature 446 (7132), 153-158, 2007 | 3726 | 2007 |
| Localization of a Breast Cancer Susceptibility Gene, BRCA2, to Chromosome 13q12-13 R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ... Science 265 (5181), 2088-2090, 1994 | 2821 | 1994 |
| Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2799 | 2007 |
| Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease B Ravikumar, C Vacher, Z Berger, JE Davies, S Luo, LG Oroz, F Scaravilli, ... Nature genetics 36 (6), 585-595, 2004 | 2792 | 2004 |
| Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017 | 2677 | 2017 |
| Risks of cancer in BRCA1-mutation carriers D Ford, DF Easton, DT Bishop, SA Narod, DE Goldgar The Lancet 343 (8899), 692-695, 1994 | 2480 | 1994 |
| International network of cancer genome projects Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ... Nature 464 (7291), 993-998, 2010 | 2246 | 2010 |
| Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. DF Easton, D Ford, DT Bishop American journal of human genetics 56 (1), 265, 1995 | 2190 | 1995 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2157 | 1998 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1906 | 2012 |
| Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. DF Easton, DT Bishop, D Ford, GP Crockford American journal of human genetics 52 (4), 678, 1993 | 1847 | 1993 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1650* | 2020 |
| Cancer incidence in BRCA1 mutation carriers D Thompson, DF Easton Journal of the National Cancer Institute 94 (18), 1358-1365, 2002 | 1463 | 2002 |
| The evolutionary history of lethal metastatic prostate cancer G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ... Nature 520 (7547), 353-357, 2015 | 1422 | 2015 |
| Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants 1958 Birth Cohort Controls: Jones Richard W 18 McArdle Wendy L 18 Ring Susan ... Nature genetics 39 (11), 1329-1337, 2007 | 1422 | 2007 |
| Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. H Meijers-Heijboer, A Van den Ouweland, J Klijn, M Wasielewski, ... Nature genetics 31 (1), 2002 | 1398 | 2002 |
Paul PharoahUniversity of CambridgeVerified email at medschl.cam.ac.uk
